Literature DB >> 9489491

Humatrix, a novel myoepithelial matrical gel with unique biochemical and biological properties.

P Kedeshian1, M D Sternlicht, M Nguyen, Z M Shao, S H Barsky.   

Abstract

Myoepithelial cells in situ and in vitro exert important paracrine effects on carcinoma cells which are mediated by high expression of extracellular matrix molecules, proteinase inhibitors and angiogenic inhibitors. Myoepithelial xenografts (human matrix secreting (HMS)-X, HMS-3X and HMS-4X) established from benign human salivary gland and breast myoepithelial tumors accumulate an abundant extracellular matrix which can be extracted with 6 M urea and 2 M guanidinium hydrochloride to form a gel at 25-37 degrees C. This gel, termed Humatrix, exhibits different biochemical and biological properties than the conventional non-human matrical gels in existence, i.e. Matrigel and Vitrogen 100. Whereas Matrigel consists mainly of basement membrane molecules, e.g. laminin, type IV collagen and heparan sulfate proteoglycan, and Vitrogen 100 consists mainly of non-basement membrane molecules, e.g. type I and type III collagen, Humatrix contains significant amounts of both basement membrane and non-basement membrane molecules, including large amounts of chondroitin sulfate proteoglycan. Like Matrigel, Humatrix contains bound growth factors, including epidermal growth factor (EGF) and insulin-like growth factor-I (IGF-I); unlike Matrigel, which contains predominantly significant quantities of bound proteinases, including tissue-type plasminogen activator (tPA), matrix metalloproteinase (MMP)-2 and MMP-9, and angiogenic factors, including basic fibroblast growth factor (bFGF) and transforming growth factor (TGF)-beta, Humatrix contains predominantly bound proteinase inhibitors such as protease nexin II (PN-II) and alpha1-antitrypsin and angiogenic inhibitors such as thrombospondin-1. Humatrix selectively stimulates the growth and tumorigenicity of human myoepithelial cell lines but inhibits invasion, angiogenesis and metastasis of other non-myoepithelial malignant cell lines. Because of its myoepithelial origin Humatrix represents a more natural source of extracellular matrix molecules and bound factors that carcinoma cells encounter in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9489491     DOI: 10.1016/s0304-3835(97)00429-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  Three-dimensional culture models of mammary gland.

Authors:  Jonathan J Campbell; Christine J Watson
Journal:  Organogenesis       Date:  2009-04       Impact factor: 2.500

2.  PAR2-dependent activation of GSK3β regulates the survival of colon stem/progenitor cells.

Authors:  Imen Nasri; Delphine Bonnet; Bailey Zwarycz; Emilie d'Aldebert; Sokchea Khou; Raoudha Mezghani-Jarraya; Muriel Quaranta; Corinne Rolland; Chrystelle Bonnart; Emmanuel Mas; Audrey Ferrand; Nicolas Cenac; Scott Magness; Laurianne Van Landeghem; Nathalie Vergnolle; Claire Racaud-Sultan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-16       Impact factor: 4.052

3.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Fritz Rank; Mina J Bissell; Ole William Petersen
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

Review 4.  Improving fluorescence-based assays for the in vitro analysis of cell adhesion and migration.

Authors:  Paola Spessotto; Emiliana Giacomello; Roberto Perri
Journal:  Mol Biotechnol       Date:  2002-03       Impact factor: 2.860

Review 5.  Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.

Authors:  Sanford H Barsky; Nina J Karlin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.